Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A phase III clinical trial of MicroPine for myopia

Trial Profile

A phase III clinical trial of MicroPine for myopia

Planning
Phase of Trial: Phase III

Latest Information Update: 31 Aug 2018

At a glance

  • Drugs Atropine (Primary)
  • Indications Myopia
  • Focus Registrational; Therapeutic Use
  • Sponsors Eyenovia
  • Most Recent Events

    • 31 Aug 2018 According to an Eyenovia Inc. media release, the company is planning to initiate the trial in H1 2019.
    • 09 Jul 2018 According to an Eyenovia Inc. media release, the company is planning to initiate the trial in mid-2019.
    • 09 May 2018 According to an Eyenovia Inc. media release, the company has received positive feedback from the US FDA to advance MicroPine for progressive pediatric myopia into Phase III development with possibility of only one trial required for registration.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top